Unknown

Dataset Information

Virus replication is not required for oncolytic bovine herpesvirus-1 immunotherapy.


ABSTRACT: Oncolytic viruses are a promising approach for cancer treatment where viruses selectively target and kill cancer cells while also stimulating an immune response. Among viruses with this ability, bovine herpesvirus-1 (BoHV-1) has several advantages, including observations suggesting it may not require viral replication for its anti-cancer effects. We previously demonstrated that binding and penetration of enveloped virus particles are sufficient to trigger intrinsic and innate immune signaling in normal cells, while other groups have published the efficacy of non-replicating viruses as viable immunotherapies in different cancer models. In this work, we definitively show that live and UV-inactivated (UV) (non-replicating) BoHV-1-based regimens extend survival of tumor-bearing mice to similar

SUBMITTER: Baracuhy EM 

PROVIDER: S-EPMC11650296 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature